Preparing demonstration missions for collaborative Earth Observation and Satellite telecommunication for Space solutions

Closed

Code: 37588 | Identifier Code: HORIZON-CL4-2025-02-SPACE-32 | Programme name: 2939 | Sub-program: Digital, Industry & Space (Cluster 4)(2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 25/09/2025

The research and innovation (R&I) priorities focus on enhancing satellite communication (SatCom) and Earth Observation (EO) capabilities through advanced technologies. For SatCom, this includes end-to-end mission capabilities such as seamless integration with terrestrial networks, inter-satellite connectivity, reconfigurable payloads, and interoperability with 5G/6G networks. Emphasis is placed on building flexible testbeds and ensuring satellites can act as nodes in distributed systems. For EO, key areas include on-board processing using AI and machine learning for multi-spectral image analysis, improved data transmission, and standardized ground segment interfaces. Digitalisation of EO instruments and miniaturization of equipment are also important. Cross-cutting innovations for both EO and SatCom involve developing secure, flexible, and environmentally efficient systems, with a focus on shared resources, intelligent data fusion, and high-performance processing technologies.

Boosting the translation of biotech research into innovative health therapies

Closed

Code: 37587 | Identifier Code: HORIZON-HLTH-2025-01-TOOL-05 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

The Commission Communication ‘Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU’  has recently identified research and technology transfer to the market as a major challenge for the biotechnology sector.

This topic aims to speed up the development of innovative biotechnology-based therapies by supporting the initial phases of clinical research.

SMEs play a key role in the EU’s potential to innovate, with most biotechnology-derived drugs in development being progressed by SMEs and small biotech companies.

Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)

Closed

Code: 37583 | Identifier Code: HORIZON-HLTH-2025-01-TOOL-03 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

The availability of large-scale multimodal health data, scientific information, and novel Generative AI models, combined with high-performance computing capacities offer an unprecedented opportunity for researchers to achieve breakthroughs in our understanding of disease development and to develop new predictive models for disease management, personalised treatment solutions and personalised care pathways. 

Advancing cell secretome-based therapies

Closed

Code: 37580 | Identifier Code: HORIZON-HLTH-2025-01-TOOL-02 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

Secretome-based therapies have emerged as a promising alternative to cell-based therapies.

The secretome of cells is defined as the repertoire of molecules and biological factors that are secreted into the extracellular space and has been shown to be a key factor for therapeutic activity due to its paracrine effects.

The potential to manufacture, store and use secretome factors as off-the-shelf products, while maintaining the therapeutic benefits of cells but with fewer safety concerns, has placed the secretome at the forefront of regenerative medicine. Different cell secretomes or parts thereof have been the subject of clinical trials, but there is currently no regulatory-approved secretome-based therapy owing to several challenges.

Currently, for the majority of secretome-based therapies, the main bottlenecks are: the incomplete understanding of their mode of action, their reproducibility due to a lack of standardised manufacturing processes and a lack of potency- and quality assurance assays. Additional limitations are the characterisation of the bioactive factors and the optimisation of the delivery strategies.

Enhancing cell therapies with genomic techniques

Closed

Code: 37577 | Identifier Code: HORIZON-HLTH-2025-01-TOOL-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

Therapies based on cells, stem cells or somatic cells, have been shown to be highly effective as therapeutics for a variety of health conditions.

However, bottlenecks remain which currently hamper their safe and efficient application on a large scale.

Genome- and epigenome editing have great potential to overcome some of these bottlenecks and to lead to the next-generation of cell-based therapies.

Advancing the frontier of cell-based therapy with these tools and further translation of such research into clinically viable solutions may open up a new era of innovative therapies.

Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices

Closed

Code: 37574 | Identifier Code: HORIZON-HLTH-2025-01-IND-02 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

The regulations on Medical Devices (MDR) and In Vitro Diagnostic Medical Devices (IVDR) have introduced stricter regulatory requirements in view of ensuring a high level of patient safety and public health. The implementation of the new regulatory requirements still remains a challenge for manufacturers.

SMEs face particular challenges as they have limited resources to adapt to the new framework.

One of the main issues reported by manufacturers is the complexity and perceived unpredictability of the conformity assessment procedure involving a Notified Body.

Digital enablers and building blocks for Earth Observation and Satellite telecommunication for Space solutions

Closed

Code: 37569 | Identifier Code: HORIZON-CL4-2025-02-SPACE-31 | Programme name: 2939 | Sub-program: Digital, Industry & Space (Cluster 4)(2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 25/09/2025

This topic falls under the European Partnership on Globally Competitive Space Systems and focuses on satellite communications (SatCom), Earth Observation (EO), and new commercial space transportation solutions, as part of broader digitalisation efforts for space services. The emphasis is on accelerating the development of low- to mid-TRL technologies that enhance competitiveness, especially through digital technologies that improve data resolution, timeliness, and resilience across end-to-end SatCom and EO systems. Projects should contribute to one or more of the following outcomes: improving the performance and integration of satellite networks with terrestrial systems to maintain EU leadership in global connectivity; enabling new commercial services through digitalised space solutions; and advancing EO payloads, technologies, and data processing capabilities. Overall, the goal is to foster more flexible, reactive, and globally competitive space-based services within the EU space sector.

Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)

Closed

Code: 37568 | Identifier Code: HORIZON-HLTH-2025-01-IND-01 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

New pioneering treatments called Advanced Therapy Medicinal Products (ATMPs), including cell and gene therapies, are at the cutting edge of medicines discovery.

Owing to their precise nature, ATMPs embody personalised medicine and reflect a shift in medicine towards potentially one-time curative therapies instead of chronic therapies that mainly cure the symptoms but not the underlying cause of diseases.

Tackling high-burden for patients and under-researched medical conditions

Closed

Code: 37565 | Identifier Code: HORIZON-HLTH-2025-01-DISEASE-07 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

A number of medical conditions fail to be recognised and/or be correctly diagnosed in a significant proportion of patients.

As a consequence, they are inadequately treated and often can become a chronic and high burden for the patient.

These medical conditions, including:

1. myalgic encephalomyelitis/chronic fatigue syndrome,
2. autism,
3. gynaecological diseases,
4. low back pain,
5. other,

may be insufficiently researched even though they manifest with high prevalence.

Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)

Closed

Code: 37560 | Identifier Code: HORIZON-HLTH-2025-01-DISEASE-06 | Programme name: 2939 | Sub-program: Health (Cluster 1) (2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 16/09/2025

The European Commission is a member of the Global Alliance for Chronic Diseases (GACD).

The GACD specifically addresses NCDs and supports implementation science to improve health outcomes. This topic is launched in concertation with the other GACD members (international funding agencies) and aligned with the 10^th GACD call.

ISOS Pilot Mission Detailed Design – satAPPs component

Closed

Code: 37559 | Identifier Code: HORIZON-CL4-2025-02-SPACE-24 | Programme name: 2939 | Sub-program: Digital, Industry & Space (Cluster 4)(2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 25/09/2025

To tackle the above expected outcomes, the following R&I actions should be addressed, taking into account the provided technical annex:

• R&I to complete ISOS Pilot mission detailed mission and system design (including relevant key technology maturation) for the satAPPs component. All relevant technologies shall reach the necessary TRL.
• R&I on technologies relevant for innovative satAPPs at TRL 6 that will be used in the context of the ISOS pilot mission to demonstrate upgrade of components’ functionalities and/or payload exchange and IOD/V experiments.
• R&I on satAPP modules specifically for hosting IOD/V experiments.
• Contribution to the overall ISOS pilot mission detail design in close cooperation with other mission components, the ISOS Pilot Mission Coordination and Support Action and the ISOS Pilot Mission Advisory Group.

ISOS Pilot Mission Detailed Design – Logistics component

Closed

Code: 37554 | Identifier Code: HORIZON-CL4-2025-02-SPACE-23 | Programme name: 2939 | Sub-program: Digital, Industry & Space (Cluster 4)(2021-2027) | Start submission calls: 22/05/2025 | End submission calls: 25/09/2025

To tackle the above expected outcomes, the following R&I actions should be addressed, taking into account the provided technical annex:

• R&I to complete ISOS Pilot mission detailed mission and system design (including relevant key technology maturation) for the logistics component, demonstrating the achievement of the required TRL for all relevant technologies;
• R&I on key enabling technologies relevant for design of a logistics component that can transport cargo (i.e., satAPPs and propellant) taken from an upper stage to the HOST component;
• R&I on solutions for docking and propellant management and transfer with the HOST. Building on existing European designs is encouraged;
• Contribution to the overall ISOS pilot mission detail design in close cooperation with other mission components, the ISOS Pilot Mission Coordination and Support Action and the ISOS Pilot Mission Advisory Group.